EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer

Wei Wen, Yuehua Li, Xi Cao, Yanyan Li, Ziyi Liu, Zhuoqi Tang, Liming Xie, Rongfang He

Clinical Breast Cancer · 2024

DOI: 10.1016/j.clbc.2024.02.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2024. Verfasst von Wei Wen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China; Department…. Hauptthemen laut MEDLINE: Breast Neoplasms, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: NUDCD1 (NudC Domain Containing 1) performs an essential function in biological processes such as cell progression, migration, cell cycle, and intracellular material transport. Many solid tumors express it highly, which is a prospective biomarker and therapeutic approach. However, the expression and clinical importance of NUDCD1 across breast cancer is unclear. METHODS: The expressions of NUDCD1 in breast cancers and normal breast tissues were studied utilizing the TIMER database and immunohistochemical analysis. Subsequently, we validate the association between the expression of NUDCD1 and clinicopathologic features and prognosis of breast cancer. The immunohistochemical experiments of pathway-related molecules were done on 214 breast cancer tissue microarrays. The investigation of correlation between NUDCD1 expression and tumor immune infiltration was subsequently conducted. RESULTS: Through the utilization of bioinformatics analysis and immunohistochemical experiments, it was determined that NUDCD1 exhibited upregulation within breast cancer. Furthermore, it was discovered that an elevated expression of NUDCD1 may potentially be linked to a worse prognosis in breast cancer. Our study reveals that the PI3K/AKT/mTOR signaling pathway may perform a function in NUDCD1 regulating breast cancer progression via enrichment analysis. Furthermore, the expression of NUDCD1 may be associated with the degree of immunological infiltration. CONCLUSION: The expression of NUDCD1 was explored to be elevated in breast cancer and was observed to be correlated with a poorer prognosis. p-AKT, PI3K, AKT, mTOR, and p-mTOR expression levels underwent significant elevation in breast cancer. The function of NUDCD1 within breast cancer might be associated with the PI3K/AKT/mTOR signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesBiomarkers, TumorHumansFemalePrognosisMiddle AgedGene Expression Regulation, NeoplasticLymphocytes, Tumor-InfiltratingClinical Relevance

Stichwörter der Autor:innen

Bioinformatics analysisBreast cancerImmune infiltrationNUDCD1PI3K/AKT/mTOR pathway

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktMTOR protein, humanPhosphatidylinositol 3-KinasesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China; Department of Pathology, Yongchuan Hospital Of Chongqing Medical University, Yon…
  • Department of Medical Oncology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Department of Pathology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Department of Medical Oncology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China. Electronic address: xieliming2019@usc.edu.cn.
  • Department of Pathology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China. Electronic address: herongfang2019@fsyy.usc.edu.cn.

Zitieren

APA

Wen, W., Li, Y., Cao, X., Li, Y., Liu, Z., Tang, Z., Xie, L., & He, R. (2024). Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.02.022

Vancouver

Wen W, Li Y, Cao X, Li Y, Liu Z, Tang Z, et al. Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer. Clinical Breast Cancer. 2024. doi:10.1016/j.clbc.2024.02.022

BibTeX
@article{Wen2024,
  author = {Wen, Wei and Li, Yuehua and Cao, Xi and Li, Yanyan and Liu, Ziyi and Tang, Zhuoqi and Xie, Liming and He, Rongfang},
  title = {Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer},
  journal = {Clinical Breast Cancer},
  year = {2024},
  doi = {10.1016/j.clbc.2024.02.022}
}
Kostenlos starten →